Names | |
---|---|
Preferred IUPAC name
4,4'-Methylenebis(3-hydroxynaphthalene-2-carboxylic acid)
|
|
Other names
4,4'-Methylenebis(3-hydroxy-2-naphthoic acid)
Embonic acid |
|
Identifiers | |
3D model (JSmol)
|
|
{{{Beilstein}}} | |
ChEBI | |
ChemSpider | |
ECHA InfoCard | 100.004.545 |
EC Number | 204-998-0 |
MeSH | [www.nlm.nih.gov/cgi/show_data.php?acc={{{MeSH}}} {{{MeSH}}}] |
PubChem CID
|
|
RTECS number | QL2180000 |
UNII | |
|
|
|
|
Properties | |
C23H16O6 | |
Molar mass | 388.38 g·mol−1 |
Melting point | ≥300 °C |
log P | 6.169 |
Acidity (pKa) | 2.675 |
Hazards | |
Main hazards | Causes skin irritation Causes serious eye irritation |
EU classification (DSD) (outdated)
|
Xi |
R-phrases (outdated) | R36/37/38 |
S-phrases (outdated) | S26 S36 |
Except where otherwise noted, data are given for materials in their standard state (at 25 °C [77 °F], 100 kPa).
|
|
Infobox references | |
Causes serious eye irritation
May cause respiratory irritation
Pamoic acid, also called embonic acid, is a naphthoic acid derivative. Salts and esters of pamoic acid are known as pamoates or embonates. It can be prepared by the reaction of 2-hydroxy-3-naphthoic acid with formaldehyde.
In pharmacology, the salt form of pamoic acid (pamoate ion) can be used as a counter ion of a drug compound to increase the solubility of the drug in water. The presence of multiple oxygen atoms enables significant hydrogen bonding to occur. Hydrogen bonds facilitate the dissolution of compounds in water.
Pamoic acid has agonist activity for the orphan G protein-coupled receptor GPR35 by which it activates ERK and beta-arrestin2, and causes antinociceptive activity. Although (like other drug salts) it has been considered an inactive compound by the FDA, these recent data suggest that its permitted uses may need to be reexamined.